Panbela Therapeutics (PBLA) Stock Chart & Stock Price History $0.25 +0.01 (+2.29%) As of 01:01 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock Panbela Therapeutics Stock Price Performance The Panbela Therapeutics (PBLA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 45.47%, with a year-to-date return of -35.42%. In the past month, the stock has decreased 28.50%, reflecting recent market activity. As of the latest close, Panbela Therapeutics traded at $0.24 with a market cap of $1.17 million and volume of 2,539 shares. Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.84%1 Month Performance-28.50%3 Month Performance-41.31%Year-To-Date Performance-35.42%1 Year Performance-45.47% PBLA Stock Chart for Thursday, May, 22, 2025 PBLA Chart by TradingView Panbela Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/22/2025$0.24$0.25+2.29%$0.25$0.2419,872 shs$1.19 million05/21/2025$0.25$0.24-2.60%$0.25$0.242,539 shs$1.17 million05/20/2025$0.25$0.25-0.20%$0.25$0.241,953 shs$1.20 million05/19/2025$0.25$0.25-1.28%$0.27$0.2517,744 shs$1.20 million05/16/2025$0.30$0.25-16.67%$0.30$0.2522,458 shs$1.21 million05/15/2025$0.30$0.30$0.30$0.2614,826 shs$1.46 million05/14/2025$0.25$0.30+19.95%$0.30$0.2614,826 shs$1.46 million05/13/2025$0.30$0.25-15.22%$0.31$0.25695 shs$1.21 million05/12/2025$0.31$0.30-5.21%$0.31$0.2412,973 shs$1.43 million05/09/2025$0.32$0.31-1.21%$0.31$0.317,755 shs$1.51 million Get the Latest News and Ratings for PBLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2025$0.32$0.32$0.38$0.31792 shs$1.53 million05/07/2025$0.24$0.32+32.97%$0.39$0.264,648 shs$1.53 million05/06/2025$0.24$0.24-2.71%$0.26$0.247,779 shs$1.15 million05/05/2025$0.24$0.24+1.46%$0.29$0.2445,385 shs$1.18 million05/02/2025$0.23$0.24+2.39%$0.29$0.243,994 shs$1.17 million05/01/2025$0.27$0.23-11.55%$0.29$0.23453 shs$1.14 million04/30/2025$0.26$0.27+1.81%$0.27$0.2641,421 shs$1.29 million04/29/2025$0.26$0.26$0.34$0.2683,799 shs$1.26 million04/28/2025$0.32$0.26-18.91%$0.34$0.2683,799 shs$1.26 million04/25/2025$0.32$0.32+0.63%$0.34$0.29377 shs$1.55 million04/24/2025$0.34$0.32-7.05%$0.36$0.291,081 shs$1.55 million04/23/2025$0.34$0.34$0.34$0.283,056 shs$1.67 million04/22/2025$0.32$0.34+6.82%$0.34$0.283,056 shs$1.67 million04/21/2025$0.28$0.32+14.75%$0.32$0.301,874 shs$1.56 million Related Companies Evoke Pharma Stock Chart Clearmind Medicine Stock Chart Alaunos Therapeutics Stock Chart Conduit Pharmaceuticals Stock Chart Oragenics Stock Chart Sonnet BioTherapeutics Stock Chart Galecto Stock Chart Titan Pharmaceuticals Stock Chart Sunshine Biopharma Stock Chart Jaguar Health Stock Chart Receive PBLA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Panbela Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PBLA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Panbela Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Panbela Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
